November 20th 2024
The media company utilized CMS data and worked with Medicare experts to pinpoint qualities that were highly valued to consumers.
November 15th 2024
Making Adjustments to Reimbursement Models Impacting Patient Therapies in the Biosimilar Space
June 24th 2024In an interview with Pharma Commerce Editor Nicholas Saraceno, Fran Gregory, PharmD, Vice President of Emerging Therapies, Cardinal Health, discusses ways that changes made to reimbursement models are affecting patient therapies in the biosimilar space.